Lisanti Capital Growth’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.18M Sell
90,565
-11,760
-11% -$474K 0.92% 49
2026
Q1
$3.39M Sell
102,325
-6,850
-6% -$223K 0.85% 53
2025
Q4
$3.57M Buy
+109,175
New +$2.68M 0.85% 60
2018
Q4
Sell
-46,260
Closed -$1.71M 102
2018
Q3
$1.71M Sell
46,260
-30,755
-40% -$1.34M 0.59% 73
2018
Q2
$3.87M Buy
77,015
+35,565
+86% +$1.57M 1.48% 12
2018
Q1
$1.51M Buy
+41,450
New +$1.27M 0.73% 62

Other funds holding AXGN

Lisanti Capital Growth's AXGN Position: Q2 2026 in Review

Lisanti Capital Growth reduced its Axogen (AXGN) stake by 11% in Q2 2026, selling an estimated $474K and leaving 90,565 shares worth $4.18M. The position accounts for 0.92% of the portfolio, ranked #49.

Lisanti Capital Growth first reported a position in AXGN in Q1 2018 and has held it in 6 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Lisanti Capital Growth held 90,565 shares of Axogen worth $4.18M as of Q2 2026.
  • Lisanti Capital Growth sold 11,760 Axogen shares in Q2 2026, an estimated $474K.
  • Axogen made up 0.92% of Lisanti Capital Growth's portfolio in Q2 2026, its #49 holding.
  • Lisanti Capital Growth first reported a position in Axogen in Q1 2018 and has held it in 6 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Lisanti Capital Growth's 13F filing for Q2 2026, filed 10 Aug 2026.